Dr. Xiu-Mei Wang is currently a full professor in the School of Materials Science and Engineering at Tsinghua University. She got her Ph.D. degree in Materials Science and Engineering at Tsinghua University, China, in 2005, and continued her postdoctoral fellow at the University of Rochester and Massachusetts Institute of Technology from 2005 to 2008. Her research mainly focuses on: 1) Engineering biomaterials to direct the stem cells fate; 2) Designing bioactive hydrogel to promote nerve repair and regeneration; 3) Biomimetic bone substitutes for cranial bone regeneration. She has authored over 150 publications, including peer-reviewed journal papers, book chapters, authored books, and patents relevant to biomaterials. She was honored the State Natural Science Award by the State Council of the P.R. China, Distinguished Young Scholar of Tsinghua University, and New Century Excellent Talents by the Ministry of Education of China. She serves as the co-Editor-in-Chief of Tissue Engineering C, editors of Frontier of Materials Science, Regenerative Biomaterials, and Biomaterials Research. Helen Cui was awarded BS, MS and PhD degrees (in Materials Science, Bioengineering and Pharmaceutics) by Beijing Polytechnique University, the University of Illinois at Chicago and the State University of New Jersey, Rutgers, respectively. She joined the Center of Biomaterials of Johnson & Johnson as senior researcher from 1999 to 2011, and conducted research and product development on biomaterials based medical devices covering therapeutic areas of orthopedics, vision care, cardiology and general surgery. She has numerous publications in the peer-reviewed scientific journals in the field of biomaterials and more than 20 international and Chinese patents. She has built the Allgens USA business by delivering sustainable revenue and reaching profit goals in the US market. Her balance of U.S. and international market development experience in medical devices is uniquely suited to leverage Allgens Medical, Inc. towards more success in the years to come
